Saturday, September 30, 2023
Saturday, September 30, 2023

Contact us 561.316.3330

Dr. Stephane Ledot Joins Inspira Technologies’ Scientific Advisory Board

Dr. Stephane Ledot, a world-renowned expert in critical care and anesthesia, has joined Inspira Technologies’ Scientific Advisory Board.

Dr. Ledot is an expert in various clinical fields including Critical Care Medicine, Anesthesia, Extracorporeal Support, and Echocardiography. During his career, he has undertaken a large number of educational duties, including advanced cardiovascular life support (ACLS) instruction, critical care module for physiotherapists instruction, critical care module nursing school instruction, among others. Dr. Ledot is a highly appreciated speaker in the critical care space.
Dr. Stephane Ledot, “It is a real honor to be part of this very exciting journey. Inspira Technologies is a very dynamic company specializing in extracorporeal respiratory system innovation, and I believe it can change the paradigm of treatment of the most severe patients suffering from acute respiratory failure. I am convinced we will see new developments and applications of this technology that will translate into a better outcome for many patients.”
Dr. Ledot received his medical academic education at University Pierre et Marie Curie in Paris, France. His specialization in anesthetics and intensive care was obtained at the university de la Mediterranean in Marseille, France.
In August 2013, Dr. Ledot joined an extracorporeal life support fellowship at the National Health Services, in the United Kingdom. During that time, he was involved in the management and retrieval of patients with severe acute respiratory failure needing extracorporeal support. He stayed an additional year at Harefield Hospital to complete a fellowship in cardiothoracic anesthesia and gained some experience in the management of complex cardiac surgeries, ventricular assist devices, and heart and lung transplant.
Dr. Ledot has completed his accreditation for transesophageal echocardiography (TOE) from the European Association of Cardiovascular Imaging and holds a European Diploma in Intensive Care.
In the last few years, Dr. Ledot has served as a senior clinician in critical care and anesthetics at Royal Brompton & Harefield hospitals and became the director of the extracorporeal membrane oxygenation (ECMO) service and critical care. The Royal Brompton ECMO service is one of the largest in Europe and has been recognized as a center of excellence.
Dagi Ben-Noon, Inspira Technologies’ Chief Executive Officer, commented, “We welcome Dr. Ledot to Inspira Technologies’ Scientific Advisory Board. Dr. Ledot has valuable experience in intensive care medicine. We believe that Dr. Ledot can significantly contribute to our future efforts to introduce our innovative early extracorporeal respiratory support system, the ART device, to the international medical community.”
Medical Device News Magazine
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


CorWave Appoints Magalie Durrèche as Chief Financial Officer

Magalie Durrèche will oversee the financial management and participate in the strategic planning and fundraising of CorWave, a company developing and manufacturing a blood pump based on breakthrough technology. She succeeds Zina Hamoumi, who served as Chief Financial Officer for five years before deciding to focus on other projects.

Veracyte Names Dr Phillip G Febbo Chief Scientific Officer and Chief Medical Officer

“Phil G Febbo is an exceptional leader with a strong track record of driving successful commercialization of molecular tests through evidence development, guideline inclusion and key opinion leader support,” said Mr. Stapley. “His experience and expertise will be critical to further enhancing our ability to serve our customers and, ultimately, to transforming cancer care for patients all over the world.”

GrayMatters Health Expands US Executive Team, Including Appointment of Dr Aron Tendler as Chief Medical Office

Dr Aaron Tendler is a board-certified psychiatrist based in Palm Beach, Florida, bringing over 20 years of experience as an industry leader researching novel treatments for mental health disorders.

Carthera Appoints Dr Oern Stuge as Chairman of Board of Directors

Dr Oern Stuge brings 30+ years expertise with a wealth of experience in product development and commercial launches to support Carthera’s future growth.

Cytomos Appoints a New Director as £4 Mill Investment Sets Path for Commercialisation of Groundbreaking Cell Analysis Technology

The biotech company’s appointment of industry leader Dr Sharon Brownlow as Non-Executive Director further enhances Cytomos’ senior management team and its unique value proposition to key industry markets.

By using this website you agree to accept Medical Device News Magazine Privacy Policy